You searched for "Pediatric" from the Body Image.

Stage	Phase	Principal Investigator	Study prefix	Study number	Title (click hyperlink for more information)
	III	Martin Brecher, MD	NCG	154009	(COG ACNS0333) Treatment of Atypical Teratoid/Rhabhoid Tumors (AT/RT) of the Central Nervous System with Surgery, Intensive Chemotherapy and 3-D Conformal Radiation
	Pilot	Martin Brecher, MD	NCG	73606	(COG AHOD03P1) Treatment of Children with Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin's Disease (LPHD)
	III	Martin Brecher, MD	NCG	123707	COG ACNS0334) A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate
	I	Martin Brecher, MD	NCG	126208	COG ANBL0531) Response-and Biology-Based Therapy for Intermediate-risk Neuroblastoma
	III	Martin Brecher, MD	NCG	128008	(COG AAML0431) The Treatment of Down Syndrome Children with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Under the Age of 4 Years
	III	Martin Brecher, MD	NCG	111007	(COG ACNS0332) Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
	III	Martin Brecher, MD	NCG	107407	(COG ARST0332) Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
	II	Martin Brecher, MD	NCG	88906	COG AREN0321, Treatment of High Risk Renal tumors
	III	Martin Brecher, MD	NCG	92806	(COG AAML0531) A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents and Young Adults
N/A	NT	Martin Brecher, MD	NCG	51505	(COG ALTE03N1) Key Adverse Events After Childhood Cancer
	III	Martin Brecher, MD	NCG	56005	(COG AALL0331) Standard Risk B-precursor Acute Lymphoblastic Leukemia
N/A	N/A	Green	NCG		(COG AALL03N1) Understanding the Role of Adherence and Ethnic Differences in Survival After Childhood ALL
	II	Barbara Bambach, MD	NCG	63705	(PBMTC ONC-032) High Dose Temozolomide, Thiotepa and Carboplatin with Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy with 13-cis-Retinoic Acid in Patients with Recurrent/Refractory Malignant Brain Tumors
N/A	III	Martin Brecher, MD	NCG	02503	(AHOD0031): A Phase III Group-Wide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin's Disease
	III	Martin Brecher, MD	NCG	34404	(COG-ACNS0331) A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
	III	Martin Brecher, MD	NCG	118507	Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
	III	Martin Brecher, MD	NCG	123507	COG ASCT0431 (PBMTC ONC051)A Randomized Trial of Sirolimus-Based Graft versus Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Selected Patients with CR1 and CR2 ALL
	III	Martin Brecher, MD	NCG	130408	(COG ACNS0232) Radiotherapy Alone vs. Chemotherapy Followed by Response-Based Radiotherapy for Newly Diagnosed Primary CNS Germinoma
	III	Martin Brecher, MD	NCG	128408	(COG ANBL0532) Phase III Randomized Trial of Single vs. Tandem Myeloablative as Consolidation Therapy for High-Risk Neuroblastoma
High Risk Neuroblastoma	III	Martin Brecher, MD	NCG	63405	(COG ANBL0032) Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
	II	Martin Brecher, MD	NCG	131808	A Phase II Study of Trabectedin (ET-743, Yondelia) in Children with Recurrent Rhabdomyosarcoma, Ewing Sarcoma or Non-Rhabdomysarcomatous Soft Tissue Sarcomas
		Martin Brecher, MD	NCG	139608	(COG ALTE05N1) Umbrella Long-Term Follow-Up Protocol

Total number of Clinical Trials found: 22

Return to Search page